STOCK TITAN
  1. Home
  2. News
  3. INFU

InfuSystem Holdings Inc - INFU STOCK NEWS

Welcome to our dedicated news page for InfuSystem Holdings (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect InfuSystem Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of InfuSystem Holdings's position in the market.

News
InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K
Rhea-AI Summary
InfuSystem Holdings, Inc. receives notice of non-compliance from NYSE American due to delayed filing of Annual Report, cites issues with expense classification and ASC 842 adoption. Company granted Initial Cure Period of six months to file Delinquent Report with SEC to avoid delisting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
-
News
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023
Rhea-AI Summary
InfuSystem Holdings, Inc. reports a successful financial year in 2023 with record net revenues of $125.8 million, a 14% increase from 2022. Patient Services Revenue reached $76.5 million, while Device Solutions Revenue was $49.2 million, showing increases of 11% and 20% respectively. Adjusted EBITDA saw an 8% increase, with a five-year CAGR of 13% for Net Revenues and 10% for Adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.25%
Tags
earnings
-
News
InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024
Rhea-AI Summary
InfuSystem Holdings, Inc. (INFU) will release its preliminary fourth quarter and full year 2023 financial results on March 14, 2024, before the market opens. A conference call will be held at 9:00 a.m. Eastern Time on the same day to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.75%
Tags
conferences earnings
News
InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023
Rhea-AI Summary
InfuSystem Holdings, Inc. (NYSE American: INFU) is a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and healthcare providers. The company's CEO, CFO, and President will present at the Sidoti Small-Cap Virtual Investor Conference on December 6, 2023. A webcast and replay of the presentation will be available on the company's website. Investors can arrange one-on-one meetings with management by contacting the conference representative or Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
conferences
-
News
InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023
Rhea-AI Summary
INFU - InfuSystem Holdings, Inc. to Participate in Craig-Hallum’s 14th Annual Alpha Select Conference on November 16, 2023 - InfuSystem, a leading national health care service provider, will have its CEO, CFO, and President participate in the conference at the Sheraton New York Times Square. Investors can arrange virtual one-on-one meetings by contacting Craig-Hallum or Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
conferences
-
News
InfuSystem Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
InfuSystem Holdings, Inc. reported record net revenues of $31.9 million for the third quarter of 2023, representing a 17% growth from the prior year. Operating income increased 80%, net income increased 56%, and adjusted EBITDA increased 11%. The company also raised its full-year 2023 net revenue guidance to be greater than 11%, up from the previous estimate of above 10%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.38%
Tags
earnings
News
InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023
Rhea-AI Summary
InfuSystem Holdings, Inc. (NYSE American: INFU) will release its third quarter 2023 financial results on November 7, 2023, before the market opens. The company will also hold a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results. To participate, dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast on the company's website. A replay of the call will be available for the next 90 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
conferences earnings
-
News
Dignitana announces a sales and marketing partnership with InfuSystem to provide scalp cooling systems in the United States
Rhea-AI Summary
Dignitana AB announces sales and marketing partnership with InfuSystem Holdings, Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
partnership
-
News
InfuSystem to Participate in Lake Street’s 7th Annual Best Ideas Growth (BIG7) Conference September 14, 2023
Rhea-AI Summary
InfuSystem Holdings, Inc. to participate in Lake Street Capital Markets' conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
News
InfuSystem Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
earnings
Stock INFU logo
InfuSystem Holdings Inc

NYSE:INFU

INFU Rankings

#3922 Ranked by Market Cap
#683 Ranked by Stock Gains
N/A Ranked by Dividends

INFU Stock Data

170.97M
16.70M
5.98%
83.07%
1.1%
Dental Laboratories
Manufacturing
Link
United States
Rochester Hills

About INFU

infusystem is a growing healthcare company that provides infusion pumps and related products and services for patients in the home, in oncology clinics, at ambulatory surgery centers, and other sites of care from five locations serving all 50 states and canada.